[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f6ct0owkmoxswB0AV-Yb6yTFlspTQ-csRrGn1VHw6Jm0":8,"$fvJ3KPjvFwCK0OiE-fYEkRtWS3sBAsvlCCvetXmMS4lE":54,"$f4TrjrNwi4U6LQB0XE4rhdg5BdepTFOrHAtg_wJIJZSc":58},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":53},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":25,"views":26,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":27,"seoTitle":22,"seoKeywords":28,"seoDescription":29,"shelvesTime":30,"version":31,"menus":32,"menuId":34,"type":41,"quality":52,"commentCount":21,"isComment":41},45931,867673,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//illId40OjsB6XixR2m4hsD83ha1mACkR.png","郑春雷","上海电力医院","肿瘤科","副主任医师",111,0,"乳腺癌术后复发：那些关键药品的实用用药指南","","https://ystcdn.venuertc.com/venue/AI/41e30293-1b2b-43e7-91c4-a74f6d16f90b.jpg","\u003Cdiv id=\"material_title\" class=\"bc-title\">\n  乳腺癌术后复发：那些关键药品的实用用药指南\n\u003C/div>\n\n\u003Cdiv class=\"bc-section\">\n  \u003Cdiv class=\"bc-section-header bc-bg-1\">\n    \u003Cspan class=\"bc-icon\">💊\u003C/span> 药品概览与主要应用\n  \u003C/div>\n  \u003Cdiv class=\"bc-section-content\">\n    \u003Cp>在乳腺癌术后复发的药物治疗中，你通常会听到像氟维司群、依维莫司、来曲唑、CDK4/6抑制剂、卡培他滨、艾立布林、白蛋白紫杉醇和卡铂等名称。这些药品各司其职，有的负责抑制肿瘤生长，有的用来延缓细胞分裂，也有些用于控制激素水平。本文将细致拆解这类药品在实际用药中的八大细节，帮你避开常见误区。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bc-section\">\n  \u003Cdiv class=\"bc-section-header bc-bg-2\">\n    \u003Cspan class=\"bc-icon\">⏰\u003C/span> 01. 服用时间与方法：每种药各有“节奏感”\n  \u003C/div>\n  \u003Cdiv class=\"bc-section-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>来曲唑、氟维司群（靶向内分泌药）\u003C/b>：来曲唑每天一次，固定时间口服更易记忆，无需空腹，但建议和水送服。氟维司群为注射剂，一般每月两次，用药时请到医疗机构完成注射。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>卡培他滨（口服化疗药）\u003C/b>：必须在餐后0.5小时内足量温水整片吞服，需严格遵守12小时间隔。切勿自行增减次数。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>白蛋白紫杉醇、艾立布林、卡铂（注射化疗药）\u003C/b>：必须由专业医务人员静脉注射。治疗日程通常为1-3周一次，每种药物具体周期由医生评估后确定，切勿自行更改给药间隔。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"bc-tip bc-tip-light\">正确做法：定时服用，按医生安排严格配合进药时点，遇到漏服时切勿自行补服，请联系医生。\u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bc-section\">\n  \u003Cdiv class=\"bc-section-header bc-bg-3\">\n    \u003Cspan class=\"bc-icon\">🧪\u003C/span> 02. 剂型特征与服用技巧：不同形态不同要求\n  \u003C/div>\n  \u003Cdiv class=\"bc-section-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>卡培他滨和来曲唑\u003C/b>：属于口服片剂。需要整个吞服，禁止咀嚼、压碎或掰开，以免影响药效和增加不良反应。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>氟维司群、艾立布林、紫杉醇、卡铂\u003C/b>：为注射剂型，需到医院由专人操作。部分药物输注时间长（如紫杉醇可达1小时），注射当天建议陪同，预防晕厥等意外。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>依维莫司（免疫抑制剂/靶向药）\u003C/b>：为口服片剂，可整片吞服，需用常温水，勿用含咖啡因或果汁饮品送服。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"bc-tip bc-tip-light\">需要注意：遇到吞咽困难时，不要擅自掰碎药片，应寻求医生建议。\u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bc-section\">\n  \u003Cdiv class=\"bc-section-header bc-bg-4\">\n    \u003Cspan class=\"bc-icon\">📋\u003C/span> 03. 药物的专属作用机制\n  \u003C/div>\n  \u003Cdiv class=\"bc-section-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>来曲唑（芳香化酶抑制剂）\u003C/b>：主要通过减少体内雌激素的产生，对雌激素敏感性肿瘤有抑制作用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>氟维司群\u003C/b>：抑制雌激素受体，并加快其降解，使肿瘤细胞失去激素信号支持。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>CDK4/6抑制剂\u003C/b>：干扰细胞分裂周期，延迟肿瘤细胞增殖。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>依维莫司\u003C/b>：干预细胞生长信号通路，抑制肿瘤增长。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>卡培他滨、艾立布林、白蛋白紫杉醇、卡铂\u003C/b>：分别通过影响DNA合成、微管结构和细胞分裂过程，抑制或破坏肿瘤细胞，减少恶性进展。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"bc-tip bc-tip-colorful\">简单理解：每种药都有各自独特“攻击方式”，单独或联合应用提高治疗效果。\u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bc-section\">\n  \u003Cdiv class=\"bc-section-header bc-bg-5\">\n    \u003Cspan class=\"bc-icon\">⚠️\u003C/span> 04. 用药禁忌那些事：一定要看清说明书\n  \u003C/div>\n  \u003Cdiv class=\"bc-section-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>来曲唑、氟维司群\u003C/b>：禁用于孕妇和哺乳期女性；有过敏史禁用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>CDK4/6抑制剂、依维莫司\u003C/b>：严重肝功能损害患者禁用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>卡培他滨、卡铂、艾立布林、紫杉醇\u003C/b>：骨髓功能差、白细胞持续低下者禁用。卡培他滨还需避免与重度肾功能障碍患者共同使用。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"bc-tip bc-tip-red\">特别提醒：出现药物过敏史、孕期或哺乳期，一定要主动向医生说明，严格遵守禁忌条目。\u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bc-section\">\n  \u003Cdiv class=\"bc-section-header bc-bg-6\">\n    \u003Cspan class=\"bc-icon\">🔄\u003C/span> 05. 药物相互作用：合用需格外小心\n  \u003C/div>\n  \u003Cdiv class=\"bc-section-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>依维莫司\u003C/b>：和葡萄柚汁、圣约翰草合用会影响药物浓度，可能导致疗效下降或副作用上升。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>卡培他滨\u003C/b>：不能与华法林（常用抗凝药）合用，否则出血风险增高；同用苯妥英时需监测药物水平。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>紫杉醇、艾立布林、卡铂\u003C/b>：常需和其他化疗药联合，但合用时白细胞计数下降风险会增加，务必动态监测血象。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>CDK4/6抑制剂\u003C/b>：合用部分强效CYP3A4抑制剂/诱导剂时可改变药物血药浓度，需调整剂量。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"bc-tip bc-tip-gold\">正确做法：配药找医生，服药时查清同时吃的所有药品，避免自己随意加减药或服用保健品。\u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bc-section\">\n  \u003Cdiv class=\"bc-section-header bc-bg-7\">\n    \u003Cspan class=\"bc-icon\">🧍‍♀️\u003C/span> 06. 特殊人群的用药调整标准\n  \u003C/div>\n  \u003Cdiv class=\"bc-section-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>老年患者\u003C/b>：多数药品（如卡培他滨、依维莫司）肝肾功能下降时要减量或延长间隔，最好定期监测肾功能。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>肝肾损害者\u003C/b>：严重肝功能异常的患者，来曲唑、依维莫司基本禁用。轻中度损害需调整剂量。肾功能受损时卡培他滨剂量需下调。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>妊娠与哺乳期\u003C/b>：所有相关药品均应避免使用，发生意外用药时需立即就医评估。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"bc-tip bc-tip-blue\">正确做法：老龄或肝肾问题人群用药前主动说明病史，全程严密监测功能指标。\u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bc-section\">\n  \u003Cdiv class=\"bc-section-header bc-bg-8\">\n    \u003Cspan class=\"bc-icon\">🥴\u003C/span> 07. 常见不良反应和处理要诀\n  \u003C/div>\n  \u003Cdiv class=\"bc-section-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>卡培他滨、CDK4/6抑制剂、化疗药物\u003C/b>：消化道反应如恶心、手足麻木、腹泻较为常见。有的患者会出现骨髓抑制表现，比如白细胞减少、易感染。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>依维莫司、氟维司群\u003C/b>：口腔溃疡、皮疹、肝酶升高等。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>白蛋白紫杉醇、艾立布林、卡铂\u003C/b>：可能出现脱发、麻木、关节疼等神经症状。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"bc-tip bc-tip-red\">需要注意：如出现高热、持久呕吐、皮疹、突发乏力等异常，及时停药并尽快就医。别用市售药自行处理！\u003C/div>\n    \u003Cdiv class=\"bc-case\">临床上使用卡培他滨时，不少患者出现手足综合征，需要暂停或减量处理，有明显症状应主动告诉医生。\u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bc-section\">\n  \u003Cdiv class=\"bc-section-header bc-bg-9\">\n    \u003Cspan class=\"bc-icon\">🌡️\u003C/span> 08. 储存方法与有效期：细节关乎疗效\n  \u003C/div>\n  \u003Cdiv class=\"bc-section-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>卡培他滨、来曲唑、依维莫司等片剂\u003C/b>：存放在阴凉干燥处，最好避光密封，避免水汽侵袭和阳光直射。室温保存（25℃以下），不建议放冰箱。\u003C/li>\n      \u003Cli>\n        \u003Cb>注射剂型\u003C/b>：由医疗机构统一管理，如自行保存未用完药物，需严格按照说明书要求低温冷藏，绝对不能与食物同放。\u003C/li>\n      \u003Cli>\n        \u003Cb>过期药品\u003C/b>：切勿自行服用，按规定交由药店或医院回收；不要随意丢弃，以免误食或污染环境。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"bc-tip bc-tip-purple\">正确做法：药品存放远离儿童，避免潮湿和高温，过期一律不再使用。\u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bc-section\">\n  \u003Cdiv class=\"bc-section-header bc-bg-10\">\n    \u003Cspan class=\"bc-icon\">🔑\u003C/span> 09. 漏服、误服与过量的现场处理\n  \u003C/div>\n  \u003Cdiv class=\"bc-section-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>口服药物（如卡培他滨、来曲唑）\u003C/b>：若忘记服药，想起来后如果距离下次服药还有4小时可及时补服，如临近下次服药则跳过一次，不要加倍。\u003C/li>\n      \u003Cli>\n        \u003Cb>误服/过量服用\u003C/b>：可能带来中毒反应（如严重呕吐、晕厥），第一时间就医，携带药品包装，以便医生判断剂量。\u003C/li>\n      \u003Cli>\n        \u003Cb>注射药物\u003C/b>：必须由专业人员操作，家庭中不可能自己注射，避免误用风险。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"bc-tip bc-tip-red\">特别提醒：绝不要用别人的药品自行调剂剂量。如有不适立即联系医务人员。\u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bc-section\">\n  \u003Cdiv class=\"bc-section-header bc-bg-11\">\n    \u003Cspan class=\"bc-icon\">📑\u003C/span> 10. 实际用药案例及用药经验总结\n  \u003C/div>\n  \u003Cdiv class=\"bc-section-content\">\n    \u003Cul>\n      \u003Cli>有位62岁女性患者，在使用卡培他滨和后续联合化疗药过程中，因骨髓抑制导致血象下降，经过调整剂量和延长间隔后成功恢复，说明高龄及多线用药者需密切监测血常规并根据耐受性调整方案。\u003C/li>\n      \u003Cli>临床上在使用依维莫司合并激素类药品时，监测口腔溃疡和肝功能变化，发现异常立即减量或暂停，有效降低了并发症发生率。\u003C/li>\n      \u003Cli>有患者注射白蛋白紫杉醇时出现过敏反应，经过去除风险药物联合后安全完成用药，实际用药过程中任何不适都应及时报告专业人员。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"bc-tip bc-tip-blue\">正确做法：遇到副作用，优先和医生沟通，绝不私自处理或停药。\u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bc-section bc-section-summary\">\n  \u003Cdiv class=\"bc-section-header bc-bg-summary\">\n    \u003Cspan class=\"bc-icon\">✅\u003C/span> 总结与建议\n  \u003C/div>\n  \u003Cdiv class=\"bc-section-content\">\n    \u003Cp>药物治疗是乳腺癌术后复发管理的关键环节，科学用药不仅事关疗效，更直接影响安全。记得：按时足量、剂型不变、严格禁忌、规避相互作用、觉察不良反应、善用专业支持，是安全用药的六大法宝。家人协助、定期检测、主动报告异状可进一步提升疗效和安全边界。以后每次用药，不妨多问、多查，养成良好习惯，安全才是硬道理。\u003C/p>\n    \u003Cp class=\"bc-highlight-info\">再次提醒：如出现疑似异常反应，及时就医，不要用其他药物自行缓解。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bc-section bc-section-references\">\n  \u003Cdiv class=\"bc-section-header bc-bg-reference\">\n    \u003Cspan class=\"bc-icon\">📚\u003C/span> 参考文献（References）\n  \u003C/div>\n  \u003Cdiv class=\"bc-section-content\">\n    \u003Cul>\n      \u003Cli>\n        Baselga, J., et al. (2012). Everolimus in postmenopausal hormone-receptor–positive advanced breast cancer. \u003Ci>New England Journal of Medicine\u003C/i>, 366(6), 520–529.\n      \u003C/li>\n      \u003Cli>\n        Finn, R. S., et al. (2016). Palbociclib and Letrozole in Advanced Breast Cancer. \u003Ci>New England Journal of Medicine\u003C/i>, 375(20), 1925–1936.\n      \u003C/li>\n      \u003Cli>\n        Verma, S., et al. (2012). Trastuzumab emtansine for HER2-positive advanced breast cancer. \u003Ci>New England Journal of Medicine\u003C/i>, 367(19), 1783–1791.\n      \u003C/li>\n      \u003Cli>\n        Twelves, C., et al. (2005). Capecitabine as first-line treatment in metastatic breast cancer: a phase II study. \u003Ci>Annals of Oncology\u003C/i>, 16(5), 879–886.\n      \u003C/li>\n      \u003Cli>\n        National Comprehensive Cancer Network. (2024). NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Version 1.2024.\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n/* 独立全局样式，不影响嵌入页面其他内容 */\n.bc-title {\n  font-size: 34px;\n  font-weight: bold;\n  color: #44536b;\n  margin: 32px 0 24px 0;\n  padding: 0 18px 0 8px;\n  border-left: 8px solid #5CA1D8;\n  letter-spacing: 2px;\n}\n\n.bc-section {\n  margin-bottom: 32px;\n  background: #fff;\n  border-radius: 16px;\n  box-shadow: 0 2px 12px rgba(92,161,216,0.07);\n  overflow: hidden;\n}\n\n.bc-section-header {\n  font-size: 22px;\n  font-weight: 600;\n  line-height: 1.3;\n  padding: 20px 16px 16px 18px;\n  display: flex;\n  align-items: center;\n}\n\n.bc-icon {\n  font-size: 28px;\n  margin-right: 16px;\n}\n\n.bc-section-content {\n  font-size: 17px;\n  padding: 16px 32px 20px 38px;\n  line-height: 1.75;\n  color: #23253f;\n  background: #fcfcfb;\n}\n\n.bc-bg-1 {\n  background: linear-gradient(110deg, #e8f5fe 56%, #f9fcfe 100%);\n}\n.bc-bg-2 {\n  background: linear-gradient(120deg, #f8f5ec 26%, #f4e5d6 96%);\n}\n.bc-bg-3 {\n  background: linear-gradient(110deg, #f0f7e7 56%, #e6f4e8 100%);\n}\n.bc-bg-4 {\n  background: linear-gradient(120deg, #eeeaf5 36%, #f3f1f8 96%);\n}\n.bc-bg-5 {\n  background: linear-gradient(110deg, #fff7f7 36%, #ffe8ea 100%);\n}\n.bc-bg-6 {\n  background: linear-gradient(120deg, #eef3fa 36%, #e5effc 100%);\n}\n.bc-bg-7 {\n  background: linear-gradient(110deg, #f9ece9 56%, #fcd3c6 80%);\n}\n.bc-bg-8 {\n  background: linear-gradient(115deg, #eae2f7 56%, #f5f2fc 100%);\n}\n.bc-bg-9 {\n  background: linear-gradient(110deg, #f8f5ed 56%, #ece6d3 100%);\n}\n.bc-bg-10 {\n  background: linear-gradient(105deg, #e4f1f7 56%, #eafff9 100%);\n}\n.bc-bg-11 {\n  background: linear-gradient(110deg, #f9f7fb 56%, #ecdff5 100%);\n}\n.bc-bg-summary {\n  background: linear-gradient(100deg, #e4faed 56%, #f0faf3 100%);\n}\n.bc-bg-reference {\n  background: linear-gradient(108deg, #f7fafd 66%, #cde1f9 100%);\n}\n\n.bc-tip {\n  margin: 20px 0 10px 0;\n  padding: 12px 22px;\n  border-radius: 10px;\n  font-size: 16px;\n  display: inline-block;\n}\n.bc-tip-light {\n  background: #f6f9fc;\n  color: #306193;\n  border-left: 5px solid #5ca1d8;\n}\n.bc-tip-red {\n  background: #fff0f0;\n  color: #a94243;\n  border-left: 5px solid #e06b62;\n}\n.bc-tip-blue {\n  background: #eaf8fe;\n  color: #277694;\n  border-left: 5px solid #5ca1d8;\n}\n.bc-tip-gold {\n  background: #fffbe0;\n  color: #7d5600;\n  border-left: 5px solid #e7c342;\n}\n.bc-tip-purple {\n  background: #f3e7f6;\n  color: #7e53b5;\n  border-left: 5px solid #a98ce0;\n}\n.bc-tip-colorful {\n  background: linear-gradient(100deg, #f8fbdc 65%, #fffdf6 100%);\n  color: #738225;\n  border-left: 5px solid #e2e58e;\n}\n\n.bc-case {\n  padding: 10px 18px;\n  margin: 18px 0 6px 0;\n  border-radius: 7px;\n  background: #ebf2fa;\n  color: #20416b;\n  font-size: 16px;\n  font-style: italic;\n  border-left: 5px solid #7db1e6;\n}\n\n.bc-section-summary .bc-section-content,\n.bc-section-references .bc-section-content {\n  background: #f9fafc;\n  padding: 24px 32px 30px 38px;\n  color: #31405b;\n}\n.bc-highlight-info {\n  padding: 12px 22px;\n  border-radius: 9px;\n  background: #e9f7df;\n  color: #256c37;\n  margin-top: 18px;\n  font-weight: 600;\n}\n\nul {\n  margin-left: 12px;\n  margin-bottom: 0;\n}\nul li {\n  margin: 10px 0 10px 14px;\n  font-size: 17px;\n  line-height: 1.7;\n}\n\n/* 响应式优化 */\n@media (max-width: 900px) {\n  .bc-title {\n    font-size: 24px;\n  }\n  .bc-section-header {\n    font-size: 18px;\n    padding: 14px 4px 14px 12px;\n  }\n  .bc-section-content {\n    font-size: 15px;\n    padding: 10px 10px 14px 16px;\n  }\n  .bc-section-summary .bc-section-content,\n  .bc-section-references .bc-section-content {\n    padding: 14px 10px 18px 14px;\n  }\n}\n\u003C/style>\n\n",522,"2025-07-02 12:01:46","乳腺癌, 术后复发, 药物治疗, 用药指南, 化疗药","了解乳腺癌术后复发的关键药物治疗方案，掌握用药细节，确保疗效与安全。专为患者和家属提供实用用药指导与常见问题解答。","2025-07-08 00:06:00",2,[33],{"menuId":34,"menuName":35,"parentId":21,"orderNum":31,"path":36,"component":37,"isFrame":38,"isCache":39,"menuType":40,"visible":41,"status":21,"createDept":6,"remark":23,"createTime":42,"children":43,"columnImage":44,"columnLogo":45,"uncheckedLogo":6,"checkedLogo":6,"isHot":41,"isHome":21,"forceLogin":21,"color":46,"seoTitle":47,"seoKeywords":48,"seoDescription":49,"contentNum":6,"promotionalPoster":50,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":51,"routerPath":36,"componentInfo":37},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":55,"success":53},{"pageNo":41,"pageSize":56,"result":57,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":59,"success":53},{"authors":60,"appraiseDimensionScoresVos":61},[],[]]